MSpectraAI: a powerful platform for deciphering proteome profiling of multi-tumor mass spectrometry data by using deep neural networks
Abstract Background Mass spectrometry (MS) has become a promising analytical technique to acquire proteomics information for the characterization of biological samples. Nevertheless, most studies focus on the final proteins identified through a suite of algorithms by using partial MS spectra to comp...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | BMC Bioinformatics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12859-020-03783-0 |
id |
doaj-c7539a0edff947c288ef1112eb231b0e |
---|---|
record_format |
Article |
spelling |
doaj-c7539a0edff947c288ef1112eb231b0e2020-11-25T02:45:44ZengBMCBMC Bioinformatics1471-21052020-10-0121111510.1186/s12859-020-03783-0MSpectraAI: a powerful platform for deciphering proteome profiling of multi-tumor mass spectrometry data by using deep neural networksShisheng Wang0Hongwen Zhu1Hu Zhou2Jingqiu Cheng3Hao Yang4West China-Washington Mitochondria and Metabolism Research Center; Key Lab of Transplant Engineering and Immu-Nology, MOH, Regenerative Medicine Research Center, West China Hospital, Sichuan UniversityShanghai Institute of Materia Medica, Chinese Academy of SciencesShanghai Institute of Materia Medica, Chinese Academy of SciencesWest China-Washington Mitochondria and Metabolism Research Center; Key Lab of Transplant Engineering and Immu-Nology, MOH, Regenerative Medicine Research Center, West China Hospital, Sichuan UniversityWest China-Washington Mitochondria and Metabolism Research Center; Key Lab of Transplant Engineering and Immu-Nology, MOH, Regenerative Medicine Research Center, West China Hospital, Sichuan UniversityAbstract Background Mass spectrometry (MS) has become a promising analytical technique to acquire proteomics information for the characterization of biological samples. Nevertheless, most studies focus on the final proteins identified through a suite of algorithms by using partial MS spectra to compare with the sequence database, while the pattern recognition and classification of raw mass-spectrometric data remain unresolved. Results We developed an open-source and comprehensive platform, named MSpectraAI, for analyzing large-scale MS data through deep neural networks (DNNs); this system involves spectral-feature swath extraction, classification, and visualization. Moreover, this platform allows users to create their own DNN model by using Keras. To evaluate this tool, we collected the publicly available proteomics datasets of six tumor types (a total of 7,997,805 mass spectra) from the ProteomeXchange consortium and classified the samples based on the spectra profiling. The results suggest that MSpectraAI can distinguish different types of samples based on the fingerprint spectrum and achieve better prediction accuracy in MS1 level (average 0.967). Conclusion This study deciphers proteome profiling of raw mass spectrometry data and broadens the promising application of the classification and prediction of proteomics data from multi-tumor samples using deep learning methods. MSpectraAI also shows a better performance compared to the other classical machine learning approaches.http://link.springer.com/article/10.1186/s12859-020-03783-0Raw mass spectrometry dataProteome profilingFeature swath extractionDeep neural networksMulti-tumor typesLeave-one-out cross prediction strategy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shisheng Wang Hongwen Zhu Hu Zhou Jingqiu Cheng Hao Yang |
spellingShingle |
Shisheng Wang Hongwen Zhu Hu Zhou Jingqiu Cheng Hao Yang MSpectraAI: a powerful platform for deciphering proteome profiling of multi-tumor mass spectrometry data by using deep neural networks BMC Bioinformatics Raw mass spectrometry data Proteome profiling Feature swath extraction Deep neural networks Multi-tumor types Leave-one-out cross prediction strategy |
author_facet |
Shisheng Wang Hongwen Zhu Hu Zhou Jingqiu Cheng Hao Yang |
author_sort |
Shisheng Wang |
title |
MSpectraAI: a powerful platform for deciphering proteome profiling of multi-tumor mass spectrometry data by using deep neural networks |
title_short |
MSpectraAI: a powerful platform for deciphering proteome profiling of multi-tumor mass spectrometry data by using deep neural networks |
title_full |
MSpectraAI: a powerful platform for deciphering proteome profiling of multi-tumor mass spectrometry data by using deep neural networks |
title_fullStr |
MSpectraAI: a powerful platform for deciphering proteome profiling of multi-tumor mass spectrometry data by using deep neural networks |
title_full_unstemmed |
MSpectraAI: a powerful platform for deciphering proteome profiling of multi-tumor mass spectrometry data by using deep neural networks |
title_sort |
mspectraai: a powerful platform for deciphering proteome profiling of multi-tumor mass spectrometry data by using deep neural networks |
publisher |
BMC |
series |
BMC Bioinformatics |
issn |
1471-2105 |
publishDate |
2020-10-01 |
description |
Abstract Background Mass spectrometry (MS) has become a promising analytical technique to acquire proteomics information for the characterization of biological samples. Nevertheless, most studies focus on the final proteins identified through a suite of algorithms by using partial MS spectra to compare with the sequence database, while the pattern recognition and classification of raw mass-spectrometric data remain unresolved. Results We developed an open-source and comprehensive platform, named MSpectraAI, for analyzing large-scale MS data through deep neural networks (DNNs); this system involves spectral-feature swath extraction, classification, and visualization. Moreover, this platform allows users to create their own DNN model by using Keras. To evaluate this tool, we collected the publicly available proteomics datasets of six tumor types (a total of 7,997,805 mass spectra) from the ProteomeXchange consortium and classified the samples based on the spectra profiling. The results suggest that MSpectraAI can distinguish different types of samples based on the fingerprint spectrum and achieve better prediction accuracy in MS1 level (average 0.967). Conclusion This study deciphers proteome profiling of raw mass spectrometry data and broadens the promising application of the classification and prediction of proteomics data from multi-tumor samples using deep learning methods. MSpectraAI also shows a better performance compared to the other classical machine learning approaches. |
topic |
Raw mass spectrometry data Proteome profiling Feature swath extraction Deep neural networks Multi-tumor types Leave-one-out cross prediction strategy |
url |
http://link.springer.com/article/10.1186/s12859-020-03783-0 |
work_keys_str_mv |
AT shishengwang mspectraaiapowerfulplatformfordecipheringproteomeprofilingofmultitumormassspectrometrydatabyusingdeepneuralnetworks AT hongwenzhu mspectraaiapowerfulplatformfordecipheringproteomeprofilingofmultitumormassspectrometrydatabyusingdeepneuralnetworks AT huzhou mspectraaiapowerfulplatformfordecipheringproteomeprofilingofmultitumormassspectrometrydatabyusingdeepneuralnetworks AT jingqiucheng mspectraaiapowerfulplatformfordecipheringproteomeprofilingofmultitumormassspectrometrydatabyusingdeepneuralnetworks AT haoyang mspectraaiapowerfulplatformfordecipheringproteomeprofilingofmultitumormassspectrometrydatabyusingdeepneuralnetworks |
_version_ |
1724760644778983424 |